Clinical Trials Arena on MSN4d
Seismic Therapeutic doses first healthy participant cohort in Phase I trial of S-1117
US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases
Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
Truist Financial Corp Sells 1,117 Shares of Hayward Holdings, Inc. (NYSE:HAYW)
Truist Financial Corp lessened its holdings in Hayward Holdings, Inc. (NYSE:HAYW – Free Report) by 6.3% during the fourth ...